TWAPF (TOWA Pharmaceutical Co) Total Equity: $1,122 Mil (As of Mar. 2026)


TWAPF TOWA Pharmaceutical Co Ltd TWAPF
86 GF Score
Price $16.83
GF Value $15.06
! 5 Warning Signs
View Full Analysis

What is TOWA Pharmaceutical Co Total Equity?

TOWA Pharmaceutical Co TWAPF -30.88% 86 Total Equity is $1,122 Mil as of Mar. 2026. GuruFocus rates TWAPF with a GF Score™ of 86/100 and a GF Value™ of $15.06. The stock has 5 warning signs investors should review.

TOWA Pharmaceutical Co's total equity for the quarter that ended in Mar. 2026 was $1,122 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

TOWA Pharmaceutical Co Total Equity Historical Data

* Premium members only.

The historical data trend for TOWA Pharmaceutical Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TOWA Pharmaceutical Co Total Equity Chart

TOWA Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,114.61 1,024.16 1,040.54 1,151.39 1,122.38

TOWA Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,151.39 1,195.43 1,216.41 1,216.62 1,122.38
TWAPF
86GF Score
TOWA Pharmaceutical Co Ltd TWAPF
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TOWA Pharmaceutical Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

TOWA Pharmaceutical Co's Total Equity for the fiscal year that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=2995.223-1872.838
=1,122

TOWA Pharmaceutical Co's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=2995.223-1872.838
=1,122

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $1,122 Mil mean?
TOWA Pharmaceutical Co (TWAPF) has a Total Equity of $1,122 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for TOWA Pharmaceutical Co and its competitors.
Is TOWA Pharmaceutical Co's Total Equity too high?
TOWA Pharmaceutical Co's current Total Equity is $1,122 Mil. Overall, TOWA Pharmaceutical Co has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does TOWA Pharmaceutical Co's Total Equity compare to ZTS and UTHR?
TOWA Pharmaceutical Co's Total Equity of $1,122 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for TOWA Pharmaceutical Co and its competitors. TOWA Pharmaceutical Co's current Total Equity is $1,122 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TOWA Pharmaceutical Co stock overvalued right now?
TOWA Pharmaceutical Co (TWAPF) has a current Total Equity of $1,122 Mil. The stock's GF Value™ is $15.06, compared to a current price of $16.83 — trading 11.8% above its estimated fair value. The current Total Equity is $1,122 Mil. TOWA Pharmaceutical Co's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For TOWA Pharmaceutical Co (TWAPF), the current Total Equity is $1,122 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TOWA Pharmaceutical Co (TWAPF) Overvalued in 2026?

Based on GuruFocus' analysis, TOWA Pharmaceutical Co stock appears to be overvalued. The current stock price of $16.83 is trading 11.8% above its estimated GF Value™ of $15.06.

Key valuation signals for TWAPF:

  • Total Equity: $1,122 Mil
  • GF Value™: $15.06 vs. price of $16.83 (11.8% above fair value)
  • GF Score™: 86/100 with 5 warning signs

No single metric tells the full story. See the TWAPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TOWA Pharmaceutical Co Business Description

Other Exchanges 4553:Japan6QC:Germany
Address 2-11, Shinbashi-cho, Kadoma, Osaka, JPN, 571-8580
TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.
86GF Score

Get the complete analysis for TWAPF

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.83
Price
$15.06
GF Value